O
OrbiMed Portfolio holdings
AUM
$3.98B
This Quarter Return
-7.79%
1 Year Return
+13.05%
3 Year Return
+159.74%
5 Year Return
+207.27%
10 Year Return
+1,027.33%
AUM
$5.22B
AUM Growth
+$5.22B
(-18%)
Cap. Flow
-$466M
Cap. Flow
% of AUM
-8.93%
Top 10 Holdings %
Top 10 Hldgs %
39.09%
Holding
140
New
13
Increased
17
Reduced
36
Closed
24
Top Buys
| 1 |
SWTX
SpringWorks Therapeutics
SWTX
|
$161M |
| 2 |
Humana
HUM
|
$46.5M |
| 3 |
BLU
BELLUS Health Inc.
BLU
|
$45.1M |
| 4 |
MRTX
Mirati Therapeutics, Inc. Common Stock
MRTX
|
$41.7M |
| 5 |
Ultragenyx Pharmaceutical
RARE
|
$32.3M |
Top Sells
| 1 |
Agilent Technologies
A
|
$66.7M |
| 2 |
Bristol-Myers Squibb
BMY
|
$61M |
| 3 |
Boston Scientific
BSX
|
$60.4M |
| 4 |
Merck
MRK
|
$51.9M |
| 5 |
Illumina
ILMN
|
$51.6M |
Sector Composition
| 1 | Healthcare | 98.11% |
| 2 | Financials | 1.43% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
Ascendis Pharma
ASND
$11.8B
| $358M | 6.8% | 3,719,173 -127,500 | -3% | -$12.3M |
|
|
TCDA
2
DELISTED
Tricida, Inc. Common Stock
TCDA
| $343M | 6.51% | 11,114,280 | – | – |
|
|
3
Boston Scientific
BSX
$156B
| $214M | 4.07% | 5,268,700 -1,483,800 | -22% | -$60.4M |
|
4
Alector
ALEC
$238M
| $181M | 3.43% | 12,532,329 -650,000 | -5% | -$9.37M |
|
|
PRVL
5
DELISTED
Prevail Therapeutics Inc. Common Stock
PRVL
| $170M | 3.22% | 13,822,463 | – | – |
|
|
6
Merck
MRK
$210B
| $164M | 3.12% | 1,954,100 -616,000 | -24% | -$51.9M |
|
|
ALXN
7
DELISTED
Alexion Pharmaceuticals Inc
ALXN
| $163M | 3.09% | 1,663,285 -262,800 | -14% | -$25.7M |
|
|
SWTX
8
DELISTED
SpringWorks Therapeutics
SWTX
| $161M | 3.05% | +7,406,307 | New | +$161M |
|
9
Vertex Pharmaceuticals
VRTX
$100B
| $143M | 2.72% | 846,400 -126,900 | -13% | -$21.5M |
|
10
Neurocrine Biosciences
NBIX
$13.8B
| $142M | 2.69% | 1,575,170 -258,030 | -14% | -$23.3M |
|
11
Edwards Lifesciences
EW
$47.8B
| $112M | 2.12% | 507,800 -207,200 | -29% | -$45.6M |
|
12
Intuitive Surgical
ISRG
$170B
| $111M | 2.11% | 205,600 -4,700 | -2% | -$2.54M |
|
|
TPTX
13
DELISTED
Turning Point Therapeutics, Inc. Common Stock
TPTX
| $103M | 1.96% | 2,745,327 +177,777 | +7% | +$6.68M |
|
14
Thermo Fisher Scientific
TMO
$186B
| $102M | 1.94% | 351,900 -110,900 | -24% | -$32.3M |
|
15
Iovance Biotherapeutics
IOVA
$807M
| $101M | 1.92% | 5,548,326 | – | – |
|
16
Natera
NTRA
$23.1B
| $98.4M | 1.87% | 3,000,128 -224,200 | -7% | -$7.35M |
|
|
AVDR
17
DELISTED
Avedro, Inc Common Stock
AVDR
| $96.3M | 1.83% | 4,240,128 | – | – |
|
18
Inspire Medical Systems
INSP
$2.77B
| $89.8M | 1.7% | 1,471,000 | – | – |
|
|
THOR
19
DELISTED
Synthorx, Inc. Common Stock
THOR
| $86.5M | 1.64% | 5,316,355 | – | – |
|
20
NextCure
NXTC
$13.5M
| $83.6M | 1.59% | 2,711,013 | – | – |
|
|
DCPH
21
DELISTED
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
| $83.5M | 1.58% | 2,460,571 -1,157,600 | -32% | -$39.3M |
|
|
WMGI
22
DELISTED
Wright Medical Group Inc
WMGI
| $79.2M | 1.5% | 3,837,250 -350,549 | -8% | -$7.23M |
|
23
eHealth
EHTH
$118M
| $74.6M | 1.42% | 1,117,414 +207,600 | +23% | +$13.9M |
|
24
Bausch Health
BHC
$2.74B
| $72.4M | 1.37% | 3,312,300 -428,400 | -11% | -$9.36M |
|
|
LOGC
25
DELISTED
LogicBio Therapeutics, Inc. Common Stock
LOGC
| $69.9M | 1.33% | 6,466,783 | – | – |
|